Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRYO Stock Summary
In the News
CRYO Financial details
Company Rating
Buy
Market Cap
4.43K
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
0.22
P/B
-
P/C
-
P/FCF
-0.01
Quick Ratio
0.05
Current Ratio
0.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.03%
Inst Trans
0%
ROA
-285%
ROE
265%
ROC
3.84%
Gross Margin
34%
Oper. Margin
-10711%
Profit Margin
-14621%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.0E-4-0.175
52W High
-
52W Low
-
RSI
48.11
Rel Volume
4.2
Avg Volume
3.57K
Volume
15K
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
-91.67%
-
-
-
-
Beta
20.387
-
-
Volatility
0.01%, 0.01%
Prev Close
0%
Price
0.0001
Change
-99.75%
CRYO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0 | 0 | 0 | |
Net income per share | -0.03 | -0.03 | -0.05 | 0 | 0 | |
Operating cash flow per share | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | -0.03 | -0.01 | -0.03 | 0 | 0 | |
Tangible book value per share | -0.03 | -0.02 | -0.04 | 0 | 0 | |
Share holders equity per share | -0.03 | -0.01 | -0.03 | 0 | 0 | |
Interest debt per share | 0.02 | 0.02 | 0.02 | 0 | 0 | |
Market cap | 17.61M | 18.86M | 18.1M | 0 | 0 | |
Enterprise value | 18.59M | 19.77M | 19.24M | 0 | 0 | |
P/E ratio | -14.35 | -11.72 | -6.01 | 0 | 0 | |
Price to sales ratio | 54.75 | 33.8 | 879.19 | 0 | 0 | |
POCF ratio | -35.43 | -36.64 | -59.56 | 0 | 0 | |
PFCF ratio | -32.2 | -35.75 | -45.8 | 0 | 0 | |
P/B Ratio | -14.22 | -44.77 | -9.8 | 0 | 0 | |
PTB ratio | -14.22 | -44.77 | -9.8 | 0 | 0 | |
EV to sales | 57.78 | 35.43 | 934.67 | 0 | 0 | |
Enterprise value over EBITDA | -20.47 | -37.89 | -9.12 | 0 | 0 | |
EV to operating cash flow | -37.4 | -38.41 | -63.32 | 0 | 0 | |
EV to free cash flow | -33.99 | -37.48 | -48.69 | 0 | 0 | |
Earnings yield | -0.07 | -0.09 | -0.17 | 0 | 0 | |
Free cash flow yield | -0.03 | -0.03 | -0.02 | 0 | 0 | |
Debt to equity | -0.81 | -2.26 | -0.62 | 0 | 0 | |
Debt to assets | 0.77 | 0.64 | 1.09 | 0 | 0 | |
Net debt to EBITDA | -1.08 | -1.75 | -0.54 | 0 | 0 | |
Current ratio | 0.29 | 0.54 | 0.12 | 0 | 0 | |
Interest coverage | -7.34 | -1.94 | -21.24 | 0 | 0 | |
Income quality | 0.46 | 0.44 | 0.11 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.57 | 1.74 | 85.44 | 0 | 0 | |
Research and developement to revenue | 1.19 | 0.17 | 21.72 | 0 | 0 | |
Intangibles to total assets | 0.28 | 0.25 | 0.35 | 0 | 0 | |
Capex to operating cash flow | 0.1 | 0.02 | 0.3 | 0 | 0 | |
Capex to revenue | -0.16 | -0.02 | -4.44 | 0 | 0 | |
Capex to depreciation | -1.56 | -0.36 | -1.33 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.75 | 43.85 | 0 | 0 | |
Graham number | 0.12 | 0.08 | 0.19 | 0 | 0 | |
ROIC | 6.17 | -1.4 | 3.54 | 0 | 0 | |
Return on tangible assets | -1.32 | -1.45 | -4.4 | 0 | 0 | |
Graham Net | -0.05 | -0.03 | -0.05 | 0 | 0 | |
Working capital | -912.4K | -482.47K | -1.43M | 0 | 0 | |
Tangible asset value | -1.6M | -786.88K | -2.22M | 0 | 0 | |
Net current asset value | -2.15M | -1.33M | -2.71M | 0 | 0 | |
Invested capital | -0.81 | -2.26 | -0.62 | 0 | 0 | |
Average receivables | 274.13K | 415.08K | 289.39K | 39.39K | 0 | |
Average payables | 397.8K | 251.83K | 367.52K | 276.56K | 0 | |
Average inventory | 29.78K | 23.13K | 19.17K | 8.97K | 0 | |
Days sales outstanding | 374.65 | 327.12 | 1.4K | 0 | 0 | |
Days payables outstanding | 3.68K | 1.51K | 14.87K | 0 | 0 | |
Days of inventory on hand | 296.06 | 169.86 | 482.27 | 0 | 0 | |
Receivables turnover | 0.97 | 1.12 | 0.26 | 0 | 0 | |
Payables turnover | 0.1 | 0.24 | 0.02 | 0 | 0 | |
Inventory turnover | 1.23 | 2.15 | 0.76 | 0 | 0 | |
ROE | 0.99 | 3.82 | 1.63 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q4
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 0 | 0 | 0 | 0 | 0 | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
Net current asset value | 0 | 0 | 0 | 0 | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 7.43K | 0 | 0 | 0 | 0 | |
Average payables | 187.69K | 0 | 0 | 0 | 0 | |
Average inventory | 10.86K | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CRYO Frequently Asked Questions
What is American CryoStem Corporation stock symbol ?
American CryoStem Corporation is a US stock , located in Eatontown of Nj and trading under the symbol CRYO
What is American CryoStem Corporation stock quote today ?
American CryoStem Corporation stock price is $0.0001 today.
Is American CryoStem Corporation stock public?
Yes, American CryoStem Corporation is a publicly traded company.